Sino Biopharmaceutical-UnadrSBHMY
13F holders, Q1 2024 (March 31)1holders
$7.72avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Sino Biopharmaceutical-Unadr (SBHMY) in their 13F filings. The largest holder was Rhumbline Advisers ($68K).
- Company
- Sino Biopharmaceutical-Unadr
- CUSIP
- 82937X103
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | No change | 8,855 | $68K |
"% of holder's portfolio" is SBHMY's weight in each manager's 13F, not the share of Sino Biopharmaceutical-Unadr the manager owns.